CrownLux®: Information For Healthcare Professionals
CrownLux® is a unique product of gerontological action, which has no analogues and has unsurpassed efficiency for rejuvenation of the body. The research at Dmitry F. Chebotarev Institute of Gerontology of the National Academy of Medical Sciences of Ukraine (NAMS) has shown a positive effect after administration of CrownLux. The following properties of the drug were recorded:
• a slowdown in the rate of aging by 0.947 units
• the decrease in functional age by 11.63 years
• the indicators of mental performance were improved working memory for digital information increased by 25%
Visual attention and fine motor skills of the hands in the finger-tapping test (FTT) improved significantly
A decrease in lipids, (lipid-lowering effect) is recorded at the end of CrownLux a three-and-a-half- months course; as a result, the indicators mentioned above improve significantly.
Alexander Polyakov
PhD in medicine, Head of the Department of Social Gerontology and Geriatrics of Dmitry F. Chebotarev Institute of Gerontology of NAMS Ukraine.
Head of the Department of Physiology of the Kiev Medical University.
Member of the European Academy for Medicine of Aging, Switzerland.
Member of the Ukrainian Society of Aging Physiology, Ukraine.
Member of the Ukrainian Geriatrics Society.
Elena Tomarevskaya
PhD in medicine, senior researcher of the Occupational Rehabilitation Laboratory of Dmitry F. Chebotarev Institute of Gerontology of NAMS Ukraine.
Member of the American Geriatrics Society.
Responsible Secretary entitled to conduct examination at State Expert Center of the Ministry of Health of Ukraine (MZO).